John M. Matsoukas

Patras Science Park
Patra, ESYE23 26500, Greece

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications

Surface Plasmon Resonance as a Tool in Antiviral Drug Discovery Research.

Surface Plasmon Resonance as a Tool in Antiviral Drug Discovery Research.

Journal: Biosensors
Published: January 21, 2026

Structural and Computational Insights into the Angiotensin II Type 1 Receptor: Advances in Antagonist Design and Implications for Hypertension Therapy (2020-2024).

Structural and Computational Insights into the Angiotensin II Type 1 Receptor: Advances in Antagonist Design and Implications for Hypertension Therapy (2020-2024).

Journal: Biomolecules
Published: November 02, 2025

Unlocking Novel Therapeutic Potential of Angiotensin II Receptor Blockers.

Unlocking Novel Therapeutic Potential of Angiotensin II Receptor Blockers.

Journal: International journal of molecular sciences
Published: July 22, 2025

Control measures for neglected tropical diseases: vaccine updates.

Control measures for neglected tropical diseases: vaccine updates.

Journal: Expert review of vaccines
Published: June 09, 2025

Gating Mechanism for Biased Agonism at Angiotensin II Type 1 Receptors.

Gating Mechanism for Biased Agonism at Angiotensin II Type 1 Receptors.

Journal: Molecules (Basel, Switzerland)
Published: April 02, 2025

Docking Simulations of G-Protein Coupled Receptors Uncover Crossover Binding Patterns of Diverse Ligands to Angiotensin, Alpha-Adrenergic and Opioid Receptors: Implications for Cardiovascular Disease and Addiction.

Docking Simulations of G-Protein Coupled Receptors Uncover Crossover Binding Patterns of Diverse Ligands to Angiotensin, Alpha-Adrenergic and Opioid Receptors: Implications for Cardiovascular Disease and Addiction.

Journal: Biomolecules
Published: March 31, 2025

Semi-Supervised Learning for Predicting Multiple Sclerosis.

Semi-Supervised Learning for Predicting Multiple Sclerosis.

Journal: Journal of personalized medicine
Published: March 22, 2025

Tetrazoles: A multi-potent motif in drug design.

Tetrazoles: A multi-potent motif in drug design.

Journal: European journal of medicinal chemistry
Published: July 24, 2024

Computational Evidence for Bisartan Arginine Blockers as Next-Generation Pan-Antiviral Therapeutics Targeting SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses.

Computational Evidence for Bisartan Arginine Blockers as Next-Generation Pan-Antiviral Therapeutics Targeting SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses.

Journal: Viruses
Published: July 11, 2024

Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies.

Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies.

Journal: Expert opinion on therapeutic targets
Published: June 03, 2024

Myelin Oligodendrocyte Glycoprotein (MOG)35-55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple Sclerosis.

Myelin Oligodendrocyte Glycoprotein (MOG)35-55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple Sclerosis.

Journal: International journal of molecular sciences
Published: April 24, 2024

A methamphetamine vaccine using short monoamine and diamine peptide linkers and poly-mannose.

A methamphetamine vaccine using short monoamine and diamine peptide linkers and poly-mannose.

Journal: Bioorganic & medicinal chemistry
Published: April 24, 2024
Showing 1-12 of 65

Last Updated: 09/26/2026